Robert Webb - National Health Independent Director
| NHI Stock | USD 64.44 1.04 1.64% |
Director
Mr. Robert T. Webb is Independent Director of National Health Investors, Inc, since its inception in 1991. Mr. Webb is the owner of commercial buildings in the Middle Tennessee area and is a subdivision developer. Additionally, Mr. Webb is the Vice President and Treasurer of Webbs Refreshments, Inc., which was in operation serving the Middle Tennessee area since 1976. Mr. Webb served as President of Webbs Refreshments until that position was assumed by his son in 2010. He attended David Lipscomb College and received a Bachelor of Arts in business marketing from Middle Tennessee State University in 1969. Mr. Webb is Chairman of NHIs Compensation Committee, and is a member of the Audit Committee and Nominatin dg and Corporationrationrate Governance Committee. since 1991.
| Age | 76 |
| Tenure | 33 years |
| Address | 222 Robert Rose Drive, Murfreesboro, TN, United States, 37129-6346 |
| Phone | 615 890 9100 |
| Web | https://www.nhireit.com |
National Health Management Efficiency
The company has Return on Asset of 0.0448 % which means that on every $100 spent on assets, it made $0.0448 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1048 %, implying that it generated $0.1048 on every 100 dollars invested. National Health's management efficiency ratios could be used to measure how well National Health manages its routine affairs as well as how well it operates its assets and liabilities. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Return On Assets is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.000008. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Return On Assets is estimated to increase to 0.08, while Total Assets are projected to decrease to under 1.3 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Henry Cole | Global Medical REIT | 76 | |
| John Abbott | Healthcare Realty Trust | 66 | |
| Alan Gardner | Community Healthcare Trust | 67 | |
| Douglas Pasquale | Ventas Inc | 60 | |
| Glenn Rufrano | Ventas Inc | 67 | |
| Dan Wilford | Healthcare Realty Trust | 74 | |
| Charles Fernandez | Healthcare Realty Trust | 72 | |
| Roger West | Healthcare Realty Trust | 69 | |
| Kevin Jacobs | Omega Healthcare Investors | 47 | |
| Jeffrey Malehorn | Sabra Healthcare REIT | 57 | |
| Paula Crowley | Global Medical REIT | 66 | |
| Alfred Lumsdaine | Community Healthcare Trust | 50 | |
| Kapila Anand | Omega Healthcare Investors | 67 | |
| Edwin Morris | Healthcare Realty Trust | 77 | |
| Roxanne Martino | Ventas Inc | 63 | |
| Edward Braman | Healthcare Realty Trust | 64 | |
| Lawrence Horn | Community Healthcare Trust | 50 | |
| Jay Gellert | Ventas Inc | 66 | |
| Tong Chan | Global Medical REIT | 39 | |
| Sean Nolan | Ventas Inc | 52 | |
| Robert Ettl | Sabra Healthcare REIT | 58 | |
Management Performance
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0448 |
National Health Investors Leadership Team
Elected by the shareholders, the National Health's board of directors comprises two types of representatives: National Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National Health's management team and ensure that shareholders' interests are well served. National Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Roger Hopkins, Chief Accounting Officer | ||
| David Travis, Senior Vice President Chief Accounting Officer | ||
| Robert Adams, Independent Director | ||
| James Jobe, Independent Director | ||
| John Spaid, Chief Financial Officer, Executive Vice President - Finance | ||
| Eric Mendelsohn, CEO President | ||
| W Adams, Independent Chairman of the Board | ||
| Michelle Kelly, Senior Investments | ||
| Robert Webb, Independent Director | ||
| Susan Sidwell, Corporate Secretary | ||
| Dana Hambly, Director of Investor Relations | ||
| Ronald Reel, Chief Accounting Officer | ||
| Andrew Adams, Independent Chairman of the Board | ||
| Robert McCabe, Independent Director | ||
| Kimberly Ouimet, Director Resources | ||
| Colleen Schaller, Director of Investor Relations | ||
| Charlotte Swafford, Independent Director | ||
| Kristin Gaines, Chief Credit Officer | ||
| Robert Drive, IR Contact Officer | ||
| Ron Reel, Chief Accounting Officer | ||
| Kevin Pascoe, Executive VP of Investments | ||
| D Mendelsohn, Executive Vice President - Corporate Finance |
National Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is National Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0448 | ||||
| Profit Margin | 0.42 % | ||||
| Operating Margin | 0.63 % | ||||
| Current Valuation | 4.32 B | ||||
| Shares Outstanding | 43.42 M | ||||
| Shares Owned By Insiders | 4.61 % | ||||
| Shares Owned By Institutions | 63.87 % | ||||
| Number Of Shares Shorted | 818.03 K | ||||
| Price To Earning | 13.23 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the National Health Investors information on this page should be used as a complementary analysis to other National Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.13 | Revenue Per Share 7.384 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.